Increased serum and/or plasma levels of BAFF have been documented in several human autoimmune diseases such as SLE, rheumatoid arthritis, and Sjogren's syndrome, indicating the involvement of BAFF and the overactivation of B cells in the pathogenesis of these autoimmune diseases [21, 22]. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.